Stahl's Essential Psychopharmacology is intended as a primer text for this field, and can be read cover to cover by anyone from the novice to the expert. Expanded and fully revised, this third edition enlists advances in neurobiology and recent clinical developments to explain with renewed clarity the concepts underlying drug treatment of psychiatric disorders. Features of this edition are clinical advances in antipsychotic and antidepressant therapy. It includes new coverage of sleep disorders, chronic pain, and disorders of impulse control. This remains the essential text for students, scientists, psychiatrists, and other mental health professionals.
Contents
Preface; 1. Structure and function of neurons; 2. Synaptic neurotransmission and the anatomically addressed nervous system; 3. Signal transduction and the chemically addressed nervous system; 4. Transporters and g-protein linked receptors as targets of psychopharmacological drug action; 5. Ion channels and enzymes as targets of psychopharmacological drug action; 6. Psychiatric genetics; 7. Circuits in psychopharmacology; 8. From circuits to symptoms in psychopharmacology; 9. Psychosis and schizophrenia; 10. Antipsychotic agents; 11. Mood disorders; 12. Antidepressants; 13. Mood stabilizers; 14. Anxiety and anxiolytics; 15. Chronic pain, functional somatic syndromes, and their treatment; 16. Disorders of sleep and wakefulness and their treatment; 17. Disorders of cognition and their treatment; 18. Psychopharmacology of reward: drugs of abuse, obesity, and disorders of impulse control; 19. Disorders of reward, drug abuse, and their treatment.
Prize Winner
Highly Commended - British Medical Association Book Awards (2009)
Reviews
"Dr. Stahl's latest edition remains the clearest book covering all the latest advances and developments in psychopharmacology. The method of teaching through illustration and conceptual form should continue to make it very popular.....Completely revised and updated with the latest developments, this editioncaptures the shift from the receptor model to brain circuits and signal transduction cascades. The basic sciences section has been doubled to cover the advances in the understanding of the functioning of neurons, signal transduction cascades, ion channels, genetics, brain circuits, imaging, and disease models of pathophysiology. The clinical section has been expanded from the previous edition to discuss the psychiatric disorder and the corresponding malfunctioning brain circuit. This section also details the advances in the latest hypothesis of the disorder as well as the latest drugs related to the treatment of the disorder. New to this edition is a chapter on pain and the treatment of fibromyalgia and other somatic syndromes. Separate chapters now cover dementia and attention deficit disorders with the newest treatments as well as drugs that are in the pipeline. Of special note is the chapter on reward that has been expanded from substance abuse to cover disorders of sexual function, eating, and impulsivity. Unique to Dr. Stahl's books are the illustrations, which have been expanded in this edition to reflect the latest advances. Information is presented in conceptual form that makes it easier to read and understand. The book maintains a consistent format and is augmented with more graphs and tables."
--Doody's Book Review Service
"Stephen Stahl is one of the most recognizable names in psychopharmacology. He is an inspiring teacher who has a knack for synthesizing complex scientific information for students, residents, psychiatrists, and nonmedical mental health practitioners....[H]e has started publishing psychopharmacology books that are not only very readable and up-to-date, but are in my opinion the most creatively illustrated texts of psychopharmacology. My trainees rave about his books and quote them often."
--Journal of Clinical Psychiatry
Accreditation and Credit Designation Statements
The Neuroscience Education Institute is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Neuroscience Education Institute designates this educational activity for a maximum of 90.0 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Sponsorship Information
Sponsored by Neuroscience Education Institute
Support
This activity is supported solely by the sponsor. Neither the Neuroscience Education Institute nor Stephen M. Stahl, MD, PhD has received any funds or grants in support of this educational activity.
Printer friendly version
Email a colleague